Advisory Alpha, LLC Eli Lilly & CO Transaction History

Advisory Alpha, LLC

$2.78 Billion
Q3 2024

A detailed history of Advisory Alpha, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Advisory Alpha, LLC holds 3,618 shares of LLY stock, worth $2.88 Million. This represents 0.12% of its overall portfolio holdings.

Number of Shares

3,618

Previous 3,208 12.78%

Holding current value

$2.88 Million

Previous $2.9 Million 10.37%

% of portfolio

0.12%

Previous 0.12%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$772.14 - $960.02 $316,577 - $393,608	410 Added 12.78%	3,618 $3.21 Million
Q2 2024 Aug 21, 2024	BUY	$724.87 - $909.04 $141,349 - $177,262	195 Added 6.47%	3,208 $2.9 Million
Q1 2024 May 06, 2024	BUY	$592.2 - $792.28 $829,672 - $1.11 Million	1,401 Added 86.91%	3,013 $2.34 Million
Q4 2023 Jan 23, 2024	BUY	$525.19 - $619.13 $429,605 - $506,448	818 Added 103.02%	1,612 $939,000
Q3 2023 Oct 18, 2023	SELL	$434.7 - $599.3 $3.99 Million - $5.5 Million	-9,172 Reduced 92.03%	794 $426,000
Q2 2023 Jul 25, 2023	BUY	$350.74 - $468.98 $12,275 - $16,414	35 Added 0.35%	9,966 $4.67 Million
Q1 2023 May 02, 2023	BUY	$310.63 - $364.82 $24,229 - $28,455	78 Added 0.79%	9,931 $3.41 Million
Q4 2022 Jan 30, 2023	BUY	$321.55 - $374.67 $39,229 - $45,709	122 Added 1.25%	9,853 $3.6 Million
Q3 2022 Oct 12, 2022	SELL	$296.48 - $337.87 $9,783 - $11,149	-33 Reduced 0.34%	9,731 $3.15 Million
Q2 2022 Jul 15, 2022	SELL	$278.73 - $327.27 $17,002 - $19,963	-61 Reduced 0.62%	9,764 $3.17 Million
Q1 2022 May 02, 2022	BUY	$234.69 - $291.66 $21,591 - $26,832	92 Added 0.95%	9,825 $2.81 Million
Q4 2021 Feb 04, 2022	BUY	$224.85 - $279.04 $17,763 - $22,044	79 Added 0.82%	9,733 $2.69 Million
Q3 2021 Nov 09, 2021	BUY	$221.6 - $272.71 $5,318 - $6,545	24 Added 0.25%	9,654 $2.23 Million
Q2 2021 Aug 13, 2021	BUY	$180.55 - $233.54 $722 - $934	4 Added 0.04%	9,630 $2.21 Million
Q1 2021 May 10, 2021	SELL	$164.32 - $212.72 $10,680 - $13,826	-65 Reduced 0.67%	9,626 $1.8 Million
Q4 2020 Feb 16, 2021	BUY	$130.46 - $172.63 $8,218 - $10,875	63 Added 0.65%	9,691 $1.64 Million
Q3 2020 Nov 06, 2020	SELL	$146.22 - $169.13 $2,193 - $2,536	-15 Reduced 0.16%	9,628 $1.19 Million
Q2 2020 Aug 14, 2020	BUY	$136.42 - $164.18 $1.13 Million - $1.36 Million	8,303 Added 619.63%	9,643 $1.47 Million
Q1 2020 Apr 29, 2020	BUY	$119.05 - $147.35 $16,786 - $20,776	141 Added 11.76%	1,340 $214 Million
Q4 2019 Feb 14, 2020	SELL	$106.92 - $132.43 $4,597 - $5,694	-43 Reduced 3.46%	1,199 $167 Million
Q3 2019 Nov 13, 2019	BUY	$106.79 - $116.16 $132,633 - $144,270	1,242 New	1,242 $138,000
Q2 2019 Aug 16, 2019	SELL	$110.79 - $129.32 $134,499 - $156,994	-1,214 Closed	0 $0
Q1 2019 May 13, 2019	BUY	$111.31 - $131.02 $135,130 - $159,058	1,214 New	1,214 $0

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

751M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $756B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisory Alpha, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Advisory Alpha, LLC with notifications on news.

Account

Advisory Alpha, LLC Eli Lilly & CO Transaction History